Model of competitive binding of vascular endothelial growth factor and placental growth factor to VEGF receptors on endothelial cells
- 1 January 2004
- journal article
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 286 (1) , H153-H164
- https://doi.org/10.1152/ajpheart.00254.2003
Abstract
Placental growth factor (PlGF) competes with vascular endothelial growth factor (VEGF) for binding to VEGF receptor (VEGFR)-1 but does not bind VEGFR2. Experiments show that PlGF can augment the response to VEGF in pathological angiogenesis and in models of endothelial cell survival, migration, and proliferation. This synergy has been hypothesized to be due to a combination of the following: signaling by PlGF through VEGFR1 and displacement of VEGF from VEGFR1 to VEGFR2 by PlGF, causing increased signaling through VEGFR2. In this study, the relative contribution of PlGF-induced VEGF displacement to the synergy is quantified using a mathematical model of ligand-receptor binding to examine the effect on ligand-receptor complex formation of VEGF and PlGF acting together. Parameters specific to the VEGF-PlGF system are used based on existing data. The model is used to simulate in silico a specific in vitro experiment in which VEGF-PlGF synergy is observed. We show that, whereas a significant change in the formation of endothelial surface growth factor-VEGFR1 complexes is predicted in the presence of PlGF, the increase in the number of VEGFR2-containing signaling complexes is less significant; these results were shown to be robust to significant variation in the kinetic parameters of the model. Synergistic effects observed in that experiment thus appear unlikely to be due to VEGF displacement but to a shift from VEGF-VEGFR1 to PlGF-VEGFR1 complexes and an increase in total VEGFR1 complexes. These results suggest that VEGFR1 signaling can be functional in adult-derived endothelial cells.Keywords
This publication has 55 references indexed in Scilit:
- Vascular Endothelial Growth Factor–Induced Genes in Human Umbilical Vein Endothelial CellsArteriosclerosis, Thrombosis, and Vascular Biology, 2002
- Surgery for gastric cancer increases plasma levels of vascular endothelial growth factor and von Willebrand factorGastric Cancer, 2002
- Spatial Range of Autocrine Signaling: Modeling and Computational AnalysisBiophysical Journal, 2001
- Potential Mechanisms for the Regulation of Growth Factor Binding by HeparinJournal of Theoretical Biology, 2000
- Roles of two VEGF receptors, Flt-1 and KDR, in the signal transduction of VEGF effects in human vascular endothelial cellsOncogene, 2000
- Expression of Soluble VEGF Receptor 2 and Characterization of Its Binding by Surface Plasmon ResonanceBiochemical and Biophysical Research Communications, 1998
- Heparan Sulfate Proteoglycans Control Intracellular Processing of bFGF in Vascular Smooth Muscle CellsBiochemistry, 1998
- Role of placenta prowth factor (PIGF) in human extravillous trophoblast proliferation, migration and invasivenessPlacenta, 1998
- The Vascular Endothelial Growth Factor Receptor Flt-1 Mediates Biological ActivitiesJournal of Biological Chemistry, 1996
- Correlation of endothelial cell shape and wall shear stress in a stenosed dog aorta.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1986